Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12149140rdf:typepubmed:Citationlld:pubmed
pubmed-article:12149140lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:12149140lifeskim:mentionsumls-concept:C0929301lld:lifeskim
pubmed-article:12149140lifeskim:mentionsumls-concept:C0006141lld:lifeskim
pubmed-article:12149140lifeskim:mentionsumls-concept:C0025685lld:lifeskim
pubmed-article:12149140lifeskim:mentionsumls-concept:C0033414lld:lifeskim
pubmed-article:12149140lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:12149140lifeskim:mentionsumls-concept:C0596263lld:lifeskim
pubmed-article:12149140lifeskim:mentionsumls-concept:C0449258lld:lifeskim
pubmed-article:12149140lifeskim:mentionsumls-concept:C1306673lld:lifeskim
pubmed-article:12149140lifeskim:mentionsumls-concept:C1999177lld:lifeskim
pubmed-article:12149140pubmed:issue7lld:pubmed
pubmed-article:12149140pubmed:dateCreated2002-7-31lld:pubmed
pubmed-article:12149140pubmed:abstractTextModifying effects of beta-estradiol 3-benzoate (EB) and methoxychlor (MXC), a pesticide which possesses weak estrogenic activity, on 7,12-dimethylbenz(a)anthracene (DMBA)-induced mammary carcinogenesis were investigated in ovariectomized or intact female Sprague-Dawley rats. Twenty-eight weeks after a single DMBA (100 mg / kg body weight) initiation, when the incidence of mammary tumor-bearing rats had reached 75%, a number of the animals were subjected to ovariectomy in order to obtain 3 groups: i) tumor-bearing, ovariectomized group; ii) tumor-bearing, intact group; iii) no-tumor, ovariectomized group. Subsequently animals of each group were subjected to subcutaneous implantation of 0.5 mg EB or given diet containing 1000 ppm MXC for 13 weeks. Although the incidences, multiplicities and volumes of the palpable tumors gradually decreased after ovariectomy, EB treatment stimulated tumor growth in the tumor-bearing, ovariectomized group thereafter. A similar effect of EB treatment was also observed in the no-tumor, ovariectomized group. However, MXC did not show any effect in the tumor-bearing, or no-tumor ovariectomized groups, except that the multiplicity of tumors was significantly decreased by MXC treatment in the tumor-bearing, intact group. The results of our study suggest that MXC has no promotion / progression effect, but rather possesses a weak inhibitory effect, whereas the strongly estrogenic substance EB clearly enhanced DMBA-induced mammary tumorigenesis.lld:pubmed
pubmed-article:12149140pubmed:languageenglld:pubmed
pubmed-article:12149140pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12149140pubmed:citationSubsetIMlld:pubmed
pubmed-article:12149140pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12149140pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12149140pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12149140pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12149140pubmed:statusMEDLINElld:pubmed
pubmed-article:12149140pubmed:monthJullld:pubmed
pubmed-article:12149140pubmed:issn0910-5050lld:pubmed
pubmed-article:12149140pubmed:authorpubmed-author:ImaiToshioTlld:pubmed
pubmed-article:12149140pubmed:authorpubmed-author:YasuharaKazuo...lld:pubmed
pubmed-article:12149140pubmed:authorpubmed-author:TakizawaTamot...lld:pubmed
pubmed-article:12149140pubmed:authorpubmed-author:UedaMakotoMlld:pubmed
pubmed-article:12149140pubmed:authorpubmed-author:HiroseMasaoMlld:pubmed
pubmed-article:12149140pubmed:authorpubmed-author:MitsumoriKuni...lld:pubmed
pubmed-article:12149140pubmed:authorpubmed-author:TakagiHisayos...lld:pubmed
pubmed-article:12149140pubmed:authorpubmed-author:OnoderaHirosh...lld:pubmed
pubmed-article:12149140pubmed:authorpubmed-author:MatsuiTakaneTlld:pubmed
pubmed-article:12149140pubmed:issnTypePrintlld:pubmed
pubmed-article:12149140pubmed:volume93lld:pubmed
pubmed-article:12149140pubmed:ownerNLMlld:pubmed
pubmed-article:12149140pubmed:authorsCompleteYlld:pubmed
pubmed-article:12149140pubmed:pagination752-9lld:pubmed
pubmed-article:12149140pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:12149140pubmed:meshHeadingpubmed-meshheading:12149140...lld:pubmed
pubmed-article:12149140pubmed:meshHeadingpubmed-meshheading:12149140...lld:pubmed
pubmed-article:12149140pubmed:meshHeadingpubmed-meshheading:12149140...lld:pubmed
pubmed-article:12149140pubmed:meshHeadingpubmed-meshheading:12149140...lld:pubmed
pubmed-article:12149140pubmed:meshHeadingpubmed-meshheading:12149140...lld:pubmed
pubmed-article:12149140pubmed:meshHeadingpubmed-meshheading:12149140...lld:pubmed
pubmed-article:12149140pubmed:meshHeadingpubmed-meshheading:12149140...lld:pubmed
pubmed-article:12149140pubmed:meshHeadingpubmed-meshheading:12149140...lld:pubmed
pubmed-article:12149140pubmed:meshHeadingpubmed-meshheading:12149140...lld:pubmed
pubmed-article:12149140pubmed:meshHeadingpubmed-meshheading:12149140...lld:pubmed
pubmed-article:12149140pubmed:meshHeadingpubmed-meshheading:12149140...lld:pubmed
pubmed-article:12149140pubmed:meshHeadingpubmed-meshheading:12149140...lld:pubmed
pubmed-article:12149140pubmed:year2002lld:pubmed
pubmed-article:12149140pubmed:articleTitleEnhancing effects of beta-estradiol 3-benzoate but not methoxychlor on the promotion/progression stage of chemically-induced mammary carcinogenesis in ovariectomized rats.lld:pubmed
pubmed-article:12149140pubmed:affiliationDivision of Pathology, National Institute of Health Sciences, Setagaya-ku, Tokyo 158-8501, Japan. m-hirose@nihs.go.jplld:pubmed
pubmed-article:12149140pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12149140pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed